Yuce G - Search Results

1

Nitroimidazole-induced chronic hepatitis.

Ersoz G, Karasu Z, Akarca US, Gunsar F, Yuce G, Batur Y. Ersoz G, et al. Among authors: yuce g. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):963-6. doi: 10.1097/00042737-200108000-00015. Eur J Gastroenterol Hepatol. 2001. PMID: 11507363

2

Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.

Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, Ilter T, Batur Y. Gunsar F, et al. Among authors: yuce g. Antivir Ther. 2005;10(6):721-6. Antivir Ther. 2005. PMID: 16218171 Clinical Trial.

3

Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y. Günsar F, et al. Among authors: yuce g. Hepatogastroenterology. 2002 Sep-Oct;49(47):1195-200. Hepatogastroenterology. 2002. PMID: 12239904

4

Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.

Akarca US, Ersoz G, Gunsar F, Karasu Z, Saritas E, Yuce G, Batur Y. Akarca US, et al. Among authors: yuce g. Antivir Ther. 2004 Jun;9(3):325-34. Antivir Ther. 2004. PMID: 15259895 Clinical Trial.

5

Severe toxic hepatitis associated with amoxycillin and clavulanic acid.

Ersoz G, Karasu Z, Yildiz C, Akarca US, Yuce G, Batur Y. Ersoz G, et al. Among authors: yuce g. J Clin Pharm Ther. 2001 Jun;26(3):225-9. doi: 10.1046/j.1365-2710.2001.00341.x. J Clin Pharm Ther. 2001. PMID: 11422607

6

Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study.

Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, Batur Y. Oruc N, et al. Among authors: yuce g. BMC Gastroenterol. 2009 Feb 17;9:16. doi: 10.1186/1471-230X-9-16. BMC Gastroenterol. 2009. PMID: 19222849 Free PMC article. Clinical Trial.

7

Leukotriene receptor antagonism in experimental acute pancreatitis in rats.

Oruc N, Yukselen V, Ozutemiz AO, Yuce G, Celik HA, Musoglu A, Batur Y. Oruc N, et al. Among authors: yuce g. Eur J Gastroenterol Hepatol. 2004 Apr;16(4):383-8. doi: 10.1097/00042737-200404000-00003. Eur J Gastroenterol Hepatol. 2004. PMID: 15028970

8

The effect of interferon therapy on erythrocyte membrane Na+,K+ ATP activity in patients with chronic hepatitis B and C virus infections.

Kuralay F, Tanyalçin T, Kutay F, Ersöz G, Yüce G, Batur Y. Kuralay F, et al. Among authors: yuce g. Biochem Mol Biol Int. 1998 Sep;45(6):1189-98. doi: 10.1080/15216549800203422. Biochem Mol Biol Int. 1998. PMID: 9762418

9

Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients.

Ok E, Unsal A, Celik A, Zeytinoğlu A, Ersöz G, Tokat Y, Erensoy S, Akarca US, Basçi A, Yüce G. Ok E, et al. Among authors: yuce g. Nephrol Dial Transplant. 1998 Dec;13(12):3103-7. doi: 10.1093/ndt/13.12.3103. Nephrol Dial Transplant. 1998. PMID: 9870473

10

Erythrocyte membrane Na+,K+ ATP ase activity can be a marker of liver histopathology.

Kuralay F, Tanyalçin T, Kutay F, Yuce G, Ersoz G, Batur Y. Kuralay F, et al. Among authors: yuce g. Biochem Mol Biol Int. 1996 Nov;40(4):769-77. doi: 10.1080/15216549600201373. Biochem Mol Biol Int. 1996. PMID: 8950035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters